IBOV 169,295.41 ▼ 1.83% IPC MEX 71,204.98 ▼ 0.84% MERVAL 2,848,945 — — USD/BRL5.78▼ 0.13% USD/MXN18.48▼ 0.20% USD/CLP995.68▼ 0.39% USD/COP3,319▲ 0.04% USD/PEN3.41▲ 0.13% USD/ARS1,550▼ 0.02% USD/UYU40.61▲ 3.40% USD/PYG6,186▲ 2.79% USD/BOB11.59▲ 2.44% USD/DOP60.36▼ 0.38% USD/CRC442.56▲ 1.76% USD/GTQ7.64▲ 3.16% USD/HNL26.90▲ 3.00% USD/NIO36.62▲ 2.50% USD/VES913.46▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.99▲ 0.19% USD/TTD6.72▲ 1.97% EUR/BRL6.34▲ 1.70% BRENT 92.84 ▲ 0.43% WTI 86.19 ▲ 0.55% IRON ORE 161.91 — — COPPER 5.99 ▼ 0.16% GOLD 3,869 ▲ 0.42% SILVER 47.60 ▲ 1.73% SOY 1,227 ▼ 0.14% CORN 452.00 ▲ 0.72% WHEAT 608.50 ▲ 3.66% COFFEE 281.10 ▲ 0.14% SUGAR 18.08 ▼ 0.11% ORANGE JUICE 135.75 ▼ 0.40% COTTON 81.04 ▲ 5.25% COCOA 5,196 ▲ 3.05% BEEF 220.50 ▼ 0.07% CATTLE 337.25 ▼ 0.52% LITHIUM 56.84 ▼ 3.27% PETR4 44.02 ▼ 2.83% VALE3 60.70 ▼ 4.41% ITUB4 41.30 ▼ 2.29% BBDC4 14.23 ▼ 2.00% ABEV3 15.87 ▲ 0.51% BBAS3 14.95 ▼ 0.99% B3SA3 14.81 ▼ 0.54% WEGE3 50.40 ▼ 1.77% PRIO3 62.63 ▼ 1.06% SUZB3 55.50 ▲ 1.33% RENT3 29.31 ▼ 2.53% AZZA3 16.14 ▲ 1.45% CSAN3 3.09 ▼ 0.32% RAIZ4 19.11 ▼ 4.45% PCAR3 2.60 ▲ 1.56% GMAT3 4.13 ▼ 2.82% PSSA3 45.54 ▼ 1.87% CVCB3 0.79 ▼ 4.82% POSI3 3.10 ▼ 1.59% SLCE3 17.85 ▼ 2.35% NATU3 4.90 ▼ 4.48% BRKM5 2.84 ▼ 5.96% RANI3 8.19 ▲ 0.12% CSNA3 3.68 ▼ 1.08% IBOV 169,295.41 ▼ 1.83% IPC MEX 71,204.98 ▼ 0.84% MERVAL 2,848,945 — — USD/BRL 5.78 ▼ 0.11% USD/MXN 18.48 ▼ 0.19% USD/CLP 995.76 ▼ 0.38% USD/COP 3,319 ▲ 0.04% USD/PEN 3.41 ▲ 0.13% USD/ARS 1,550 ▼ 0.02% USD/UYU 40.61 ▲ 3.40% USD/PYG 6,186 ▲ 2.79% USD/BOB 11.59 ▲ 2.44% USD/DOP 60.36 ▲ 2.08% USD/CRC 442.56 ▲ 1.76% USD/GTQ 7.64 ▲ 3.16% USD/HNL 26.90 ▲ 3.00% USD/NIO 36.62 ▲ 2.50% USD/VES 913.46 ▲ 0.06% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.99 ▲ 2.99% USD/TTD 6.72 ▲ 1.97% EUR/BRL 6.35 ▲ 1.76% BRENT 92.84 ▲ 0.43% WTI 86.19 ▲ 0.55% IRON ORE 161.91 — — COPPER 5.99 ▼ 0.16% GOLD 3,869 ▲ 0.42% SILVER 47.60 ▲ 1.73% SOY 1,227 ▼ 0.14% CORN 452.00 ▲ 0.72% WHEAT 608.50 ▲ 3.66% COFFEE 281.10 ▲ 0.14% SUGAR 18.08 ▼ 0.11% ORANGE JUICE 135.75 ▼ 0.40% COTTON 81.04 ▲ 5.25% COCOA 5,196 ▲ 3.05% BEEF 220.50 ▼ 0.07% CATTLE 337.25 ▼ 0.52% LITHIUM 56.84 ▼ 3.27% PETR4 44.02 ▼ 2.83% VALE3 60.70 ▼ 4.41% ITUB4 41.30 ▼ 2.29% BBDC4 14.23 ▼ 2.00% ABEV3 15.87 ▲ 0.51% BBAS3 14.95 ▼ 0.99% B3SA3 14.81 ▼ 0.54% WEGE3 50.40 ▼ 1.77% PRIO3 62.63 ▼ 1.06% SUZB3 55.50 ▲ 1.33% RENT3 29.31 ▼ 2.53% AZZA3 16.14 ▲ 1.45% CSAN3 3.09 ▼ 0.32% RAIZ4 19.11 ▼ 4.45% PCAR3 2.60 ▲ 1.56% GMAT3 4.13 ▼ 2.82% PSSA3 45.54 ▼ 1.87% CVCB3 0.79 ▼ 4.82% POSI3 3.10 ▼ 1.59% SLCE3 17.85 ▼ 2.35% NATU3 4.90 ▼ 4.48% BRKM5 2.84 ▼ 5.96% RANI3 8.19 ▲ 0.12% CSNA3 3.68 ▼ 1.08%
since 2009
Tuesday, November 17, 2026

Covid-19 Brazil

Brazil’s health regulator denies approval of Avifavir, Russian antiviral against Covid-19

By · · 1 min read

RIO DE JANEIRO, BRAZIL – According to the vote of Director Meiruze Freitas, the drug does not meet the health regulator Anvisa’s expectations in terms of minimum safety and efficacy requirements in the context of emergency use.

“You cannot approve the use of a drug that has not shown clinical benefit in the treatment of Covid-19 and yet can lead to health risks for patients,” she said.

Meiruze Freitas
Meiruze Freitas.
RT
Ask Rio Times
17 years of Latin America reporting, on demand.
Open the full Ask Rio Times →

The drug, manufactured by Russian companies API – Technologies LLC and Joint Stock Company Chemical Diversity Research Institute – JSC CDRI, had registered the application for emergency use approval by the Vital Brazil Institute.

Avifavir is considered a new drug whose active pharmaceutical ingredient has not yet been registered by Anvisa.

In Brazil, the drug rendesivir and two monoclonal antibody dressings, consisting of casirivimab with imdevimab and banlanivimab with etesevimab, are already indicated for the treatment of Covid-19.

To date, no regulatory agency in the world has approved avifavir (favipiravir) for the treatment of Covid-19, Anvisa says.

This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →

Brazil runoff date: Sunday, October 25, poll closing times and when results start · Brazil runoff polls: Flávio 51%, Lula 49% · Kalshi and Polymarket odds

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.